Medicure (MCUJF) Stock Price, News & Analysis

Company Overview

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors. Its commercial portfolio includes branded cardiovascular products, while its research and development pipeline features small‐molecule candidates targeting acute heart failure, pulmonary hypertension and related conditions. The company leverages its regulatory and clinical expertise to shepherd assets from late‐stage development through to market access.

Since its founding in 2004, Medicure has grown by forging collaborations with both larger pharmaceutical companies and specialty distributors, aiming to accelerate product launches and maximize reach in key therapeutic segments. The senior leadership team brings decades of experience in drug development, regulatory affairs and commercial operations, positioning Medicure to advance its niche cardiovascular and critical‐care medicines to patients in need.

Key Stats

• Today's Range: $0.75 to $0.75
• 50-Day Range: $0.75 to $0.96
• 52-Week Range: $0.60 to $0.97
• Volume: N/A
• Average Volume: 165 shs
• Market Capitalization: $7.83 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MCUJF Stock Analysis - Frequently Asked Questions

How have MCUJF shares performed this year?

Medicure's stock was trading at $0.7997 at the beginning of the year. Since then, MCUJF stock has decreased by 6.2% and is now trading at $0.75.

How were Medicure's earnings last quarter?

Medicure Inc. (OTCMKTS:MCUJF) released its quarterly earnings data on Thursday, April, 23rd. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.25. The company earned $6.13 million during the quarter, compared to analysts' expectations of $3.62 million. Medicure had a negative trailing twelve-month return on equity of 41.55% and a negative net margin of 24.61%.

How do I buy shares of Medicure?

Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 4/23/2026
• Today: 5/05/2026
• Next Earnings (Estimated): 5/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MCUJF
• CIK: 1133519
• Web: www.medicure.com
• Phone: (204) 487-7412
• Fax: 204-488-9823
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.49)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.08 million
• Net Margins: -24.61%
• Pretax Margin: -23.87%
• Return on Equity: -41.55%
• Return on Assets: -25.94%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.02
• Quick Ratio: 0.77

Sales & Book Value

• Annual Sales: $20.65 million
• Price / Sales: 0.38
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.89 per share
• Price / Book: 0.84

Miscellaneous

• Outstanding Shares: 10,440,000
• Free Float: 9,090,000
• Market Cap: $7.83 million
• Optionable: Not Optionable
• Beta: 0.97